Skip navigation

Identify the Keys to Early Commercialization • Eliminate Barriers to Market Access • Harness New Technology • Ensure Post-Launch Success

October 28-29, 2019
  • Boston, MA

In an increasingly complex healthcare landscape, it is more important than ever to have an early product launch plan for your drug. Whether you are a pre-commercial biotech or an established pharmaceutical company, you’ll face many of the same challenges as you prepare the market, prepare your organization and prepare your product for a successful launch.

Join us for CBI’s 5th Annual Bio/Pharmaceutical Product Launch Summit and analyze each necessary step to innovatively plan for a new product launch. Identify best practices, KPIs and “how to” tactics for immediate implementation.

Top Reasons to Attend:

  • Hear from experts on best practices for
    pre-commercialization planning
  • Optimize your post-launch infrastructure
  • Examine the differences between launching a rare
    disease drug, biosimilar, generic or specialty drug
  • Learn to navigate the risks and complexities involved in
    accurate budgeting and forecasting
  • Find inspiration from industry leaders on ways to create
    a clear, and concise communication platform for a
    drug candidate to improve performance
  • Take internal project management to the next level —
    build strategies to utilize across multiple departments
  • Delve into government pricing strategies as you
    prepare to go-to-market
  • Gain valuable insights on how to create a market research
    studies that support product launch activities
  • Prepare for market access strategies to propel your product launch
  • Draw from technology experts on ways to improve the serialization process, name creation and packaging design

Previous Attendee Acclaim:

I thought the conference was well prepared. All the speakers were experts in their topic and delivered their message effectively. Group interaction was also great. I learned a lot
and recommend this type of conference to anyone who is preparing to launch a product in the next 3-5 years.

Executive Director, Commercialization, Noven Pharmaceuticals

5th Annual Bio/Pharmaceutical Product Launch Summit

Identify the Keys to Early Commercialization • Eliminate Barriers to Market Access • Harness New Technology • Ensure Post-Launch Success

In an increasingly complex healthcare landscape, it is more important than ever to have an early product launch plan for your drug. Whether you are a pre-commercial biotech or an established pharmaceutical company, you’ll face many of the same challenges as you prepare the market, prepare your organization and prepare your product for a successful launch.

Join us for CBI’s 5th Annual Bio/Pharmaceutical Product Launch Summit and analyze each necessary step to innovatively plan for a new product launch. Identify best practices, KPIs and “how to” tactics for immediate implementation.

Top Reasons to Attend:

  • Hear from experts on best practices for
    pre-commercialization planning
  • Optimize your post-launch infrastructure
  • Examine the differences between launching a rare
    disease drug, biosimilar, generic or specialty drug
  • Learn to navigate the risks and complexities involved in
    accurate budgeting and forecasting
  • Find inspiration from industry leaders on ways to create
    a clear, and concise communication platform for a
    drug candidate to improve performance
  • Take internal project management to the next level —
    build strategies to utilize across multiple departments
  • Delve into government pricing strategies as you
    prepare to go-to-market
  • Gain valuable insights on how to create a market research
    studies that support product launch activities
  • Prepare for market access strategies to propel your product launch
  • Draw from technology experts on ways to improve the serialization process, name creation and packaging design

Previous Attendee Acclaim:

I thought the conference was well prepared. All the speakers were experts in their topic and delivered their message effectively. Group interaction was also great. I learned a lot
and recommend this type of conference to anyone who is preparing to launch a product in the next 3-5 years.

Executive Director, Commercialization, Noven Pharmaceuticals